11β-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 8, 2003, Pages 3874-3877

  Cooper, Mark S ^a   Blumsohn, Aubrey ^b   Goddard, Philippa E ^c   Bartlett, William A ^c   Shackleton, Cedric H ^d   Eastell, Richard ^b   Hewison, Martin ^a   Stewart, Paul M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c Birmingham Heartlands/S ^*  (United Kingdom)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; COLLAGEN TYPE 1; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; OSTEOCALCIN; PREDNISOLONE; PREDNISONE; BIOLOGICAL MARKER; HSD11B2 PROTEIN, HUMAN; HYDROXYSTEROID DEHYDROGENASE; STEROID;

ADULT; ARTICLE; BONE; BONE TURNOVER; CORTICOSTEROID METABOLISM; DISEASE PREDISPOSITION; ENZYME ACTIVITY; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINE LEVEL; BLOOD; BONE DENSITY; BONE DEVELOPMENT; CLINICAL TRIAL; DRUG EFFECT; METABOLISM; URINE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; GLUCOCORTICOIDS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; MALE; OSTEOBLASTS; OSTEOGENESIS; PREDNISOLONE; STEROIDS;

EID: 0042387905     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-022025     Document Type: Article

References (24)

1. Canalis E 1996 Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447
2. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C 2000 Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000
3. Prummel MF, Wiersinga WM, Lips P, Sanders GT, Sauerwein HP 1991 The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 72:382-386
4. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-282
5. Godschalk MF, Downs RW 1988 Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 3:113-115
6. Pearce G, Tabensky DA, Delmas PD, Baker HW, Seeman E 1998 Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab 83:801-806
7. Gram J, Junker P, Nielsen HK, Bollerslev J 1998 Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men. Bone 23:297-302
8. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389
9. Carbonare LD, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ 2001 Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 16:97-103
10. Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL, Parfitt AM, Manolagas SC 2002 Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041-1048
11. Stewart PM, Krozowski ZS 1999 11β-Hydroxysteroid dehydrogenase. Vitam Horm 57:249-324
12. Canalis E, Delany AM 2002 11β-Hydroxysteroid dehydrogenase, an amplifier of glucocorticoid action in osteoblasts. J Bone Miner Res 17:987-990
13. Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M, Stewart PM 2000 Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone. Bone 27:375-381
14. Cooper MS, Rabbitt EH, Goddard PE, Bartlett WA, Hewison M, Stewart PM 2002 Osteoblastic 11β-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure. J Bone Miner Res 17:979-986
15. Bland R, Worker CA, Noble BS, Eyre LJ, Bujalska IJ, Sheppard MC, Stewart PM, Hewison M 1999 Characterization of 11β-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. J Endocrinol 161:455-464
16. Eyre LJ, Rabbitt EH, Bland R, Hughes SV, Cooper MS, Sheppard MC, Stewart PM, Hewison M 2001 Expression of 11β-hydroxysteroid dehydrogenase in rat osteoblastic cells: Pre-receptor regulation of glucocorticoid responses in bone. J Cell Biochem 81:453-462
17. Cooper MS, Bujalska I, Rabbitt E, Walker EA, Bland R, Sheppard MC, Hewison M, Stewart PM 2001 Modulation of 11β-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res 16:1037-1044
18. Rabbitt E, Lavery GG, Walker EA, Cooper MS, Stewart PM, Hewison M 2002 Pre-receptor regulation of glucocorticoid action by 11β-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation. FASEB J 16:36-44
19. Bayly GR, Bartlett WA, Jones AF 1997 A non-isotopic method for estimating 11β-hydroxysteroid dehydrogenase activity in vivo. Ann Clin Biochem 34:521-526
20. Palermo M, Shackleton CH, Mantero F, Stewart PM 1996 Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 45:605-611
21. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM 2001 Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 142:1982-1989
22. Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 12:281-289
23. Tomlinson JW, Draper N, Mackie J, Johnson AP, Holder G, Wood P, Stewart PM 2002 Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion. J Clin Endocrinol Metab 87:57-62
24. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH 1999 Cortisol metabolism in human obesity: impaired cortisone→cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84:1022-1027